{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:20:15Z","timestamp":1769023215833,"version":"3.49.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1093\/eurheartj\/ehi178","type":"journal-article","created":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T03:17:38Z","timestamp":1110943058000},"page":"1086-1093","source":"Crossref","is-referenced-by-count":11,"title":["Using BNP to develop a risk score for heart failure in primary care"],"prefix":"10.1093","volume":"26","author":[{"given":"David","family":"Adlam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Silcocks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Sparrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,3,15]]},"reference":[{"key":"key\n\t\t\t\t20171012095750_EHI178C1","unstructured":"National Service Framework\u2014Coronary Heart Disease. Department of Health, UK."},{"key":"key\n\t\t\t\t20171012095750_EHI178C2","doi-asserted-by":"crossref","unstructured":"CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Co-operative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med1987;316:1429\u20131435.","DOI":"10.1056\/NEJM198706043162301"},{"key":"key\n\t\t\t\t20171012095750_EHI178C3","doi-asserted-by":"crossref","unstructured":"SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med1991;325:293\u2013302.","DOI":"10.1056\/NEJM199108013250501"},{"key":"key\n\t\t\t\t20171012095750_EHI178C4","doi-asserted-by":"crossref","unstructured":"CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet1999;353:9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"key\n\t\t\t\t20171012095750_EHI178C5","doi-asserted-by":"crossref","unstructured":"MERIT-HF Study Group. Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet1999;353:2001\u20132007.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"key\n\t\t\t\t20171012095750_EHI178C6","doi-asserted-by":"crossref","unstructured":"Pitt B, Zannad F, Remmie WJ et\u00a0al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med1999;341:709\u2013717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"key\n\t\t\t\t20171012095750_EHI178C7","unstructured":"Wheeldon NM, MacDonald TM, Flucker CJ et\u00a0al. Echocardiography in chronic heart failure in the community. Q J Med1993;86:17\u201323."},{"key":"key\n\t\t\t\t20171012095750_EHI178C8","doi-asserted-by":"crossref","unstructured":"Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J1994;71:584\u2013587.","DOI":"10.1136\/hrt.71.6.584"},{"key":"key\n\t\t\t\t20171012095750_EHI178C9","doi-asserted-by":"crossref","unstructured":"Sparrow N, Adlam D, Cowley A et\u00a0al. The diagnosis of heart failure in general practice: implications for the UK National Service Framework. Eur J Heart Fail2003;5:349\u2013354.","DOI":"10.1016\/S1388-9842(03)00046-1"},{"key":"key\n\t\t\t\t20171012095750_EHI178C10","doi-asserted-by":"crossref","unstructured":"Davie AP, Francis CM, Caruana L et\u00a0al. Assessing diagnosis in heart failure: which features are any use? Q J Med1997;90:335\u2013339.","DOI":"10.1093\/qjmed\/90.5.335"},{"key":"key\n\t\t\t\t20171012095750_EHI178C11","doi-asserted-by":"crossref","unstructured":"Butman SM, Ewy GA, Standen JR et\u00a0al. The limited reliability of physical signs for estimating haemodynamics in chronic heart failure. JAMA1989;261:884\u2013888.","DOI":"10.1001\/jama.261.6.884"},{"key":"key\n\t\t\t\t20171012095750_EHI178C12","doi-asserted-by":"crossref","unstructured":"The task force on heart failure of the European society of cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J2001;22:1527\u20131560.","DOI":"10.1053\/euhj.2001.2783"},{"key":"key\n\t\t\t\t20171012095750_EHI178C13","doi-asserted-by":"crossref","unstructured":"Landray MJ, Lehman R, Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. BMJ2000;320:985\u2013986.","DOI":"10.1136\/bmj.320.7240.985"},{"key":"key\n\t\t\t\t20171012095750_EHI178C14","doi-asserted-by":"crossref","unstructured":"Smith H, Pickering RM, Struthers A et\u00a0al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ2000;320:906\u2013908.","DOI":"10.1136\/bmj.320.7239.906"},{"key":"key\n\t\t\t\t20171012095750_EHI178C15","doi-asserted-by":"crossref","unstructured":"Nielson OW, Hansen JF, Hilden J et\u00a0al. Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests. BMJ2000;320:220\u2013224.","DOI":"10.1136\/bmj.320.7229.220"},{"key":"key\n\t\t\t\t20171012095750_EHI178C16","doi-asserted-by":"crossref","unstructured":"Hetmanski DJ, Sparrow NJ, Curtis S et\u00a0al. Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community. Heart2000;84:440\u2013441.","DOI":"10.1136\/heart.84.4.440"},{"key":"key\n\t\t\t\t20171012095750_EHI178C17","doi-asserted-by":"crossref","unstructured":"McClure SJ, Caruana L, Davie AP et\u00a0al. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ1998;317:516\u2013519.","DOI":"10.1136\/bmj.317.7157.516"},{"key":"key\n\t\t\t\t20171012095750_EHI178C18","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Cunningham AD, Morrison CE et\u00a0al. Left ventricular dysfunction, natriuretic peptides and mortality in an urban population. Heart2001;86:21\u201326.","DOI":"10.1136\/heart.86.1.21"},{"key":"key\n\t\t\t\t20171012095750_EHI178C19","doi-asserted-by":"crossref","unstructured":"Wallen T, Landahl S, Hedner T et\u00a0al. Brain natriuretic peptide predicts mortality in the elderly. Heart1997;77:264\u2013267.","DOI":"10.1136\/hrt.77.3.264"},{"key":"key\n\t\t\t\t20171012095750_EHI178C20","doi-asserted-by":"crossref","unstructured":"Cheng V, Kazanagra R, Garcia A et\u00a0al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol2001;37:386\u2013391.","DOI":"10.1016\/S0735-1097(00)01157-8"},{"key":"key\n\t\t\t\t20171012095750_EHI178C21","doi-asserted-by":"crossref","unstructured":"Kalra PR, Struthers AD. More evidence of bedside BNP in heart failure assessment. Int J Cardiol2002;86:149\u2013152.","DOI":"10.1016\/S0167-5273(02)00410-2"},{"key":"key\n\t\t\t\t20171012095750_EHI178C22","doi-asserted-by":"crossref","unstructured":"Packer M. Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? Circulation2003;108:2950\u20132957.","DOI":"10.1161\/01.CIR.0000109205.35813.8E"},{"key":"key\n\t\t\t\t20171012095750_EHI178C23","doi-asserted-by":"crossref","unstructured":"Dobbs F, Struthers AD. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. BMJ2000;321:895.","DOI":"10.1136\/bmj.321.7265.895"},{"key":"key\n\t\t\t\t20171012095750_EHI178C24","doi-asserted-by":"crossref","unstructured":"Austin PC, Tu JV. Bootstrap methods for developing predictive models. American Statistician2004;58:131\u2013137.","DOI":"10.1198\/0003130043277"},{"key":"key\n\t\t\t\t20171012095750_EHI178C25","doi-asserted-by":"crossref","unstructured":"Harrell FE Jr, Lee KL, Califf RM et\u00a0al. Regression modelling strategies for improved prognostic prediction. Stat Med1984;3:143\u2013152.","DOI":"10.1002\/sim.4780030207"},{"key":"key\n\t\t\t\t20171012095750_EHI178C26","doi-asserted-by":"crossref","unstructured":"Wang TJ, Larson MG, Levy D et\u00a0al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med2004;350:655\u2013663.","DOI":"10.1056\/NEJMoa031994"},{"key":"key\n\t\t\t\t20171012095750_EHI178C27","doi-asserted-by":"crossref","unstructured":"Raymond I, Groenning BA, Hildebrandt PR et\u00a0al. The influence of age sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart2003;89:745\u2013751.","DOI":"10.1136\/heart.89.7.745"},{"key":"key\n\t\t\t\t20171012095750_EHI178C28","doi-asserted-by":"crossref","unstructured":"Wang TJ, Larson MG, Levy D et\u00a0al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol2002;90:254\u2013258.","DOI":"10.1016\/S0002-9149(02)02464-5"},{"key":"key\n\t\t\t\t20171012095750_EHI178C29","doi-asserted-by":"crossref","unstructured":"Sparrow N, Adlam D, Cowley A et\u00a0al. Difficulties of Introducing the National Service Framework for Heart Failure into General Practice in the UK. Eur J Heart Fail2003;5:355\u2013361.","DOI":"10.1016\/S1388-9842(03)00047-3"},{"key":"key\n\t\t\t\t20171012095750_EHI178C30","doi-asserted-by":"crossref","unstructured":"Vasan RS, Benjamin EJ, Larson MG et\u00a0al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA2002;288:1252\u20131259.","DOI":"10.1001\/jama.288.10.1252"},{"key":"key\n\t\t\t\t20171012095750_EHI178C31","doi-asserted-by":"crossref","unstructured":"Johnson-Wendy, Omland-Torbj\u00f8rn, Hall-Christian et\u00a0al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol2002;39:1623\u20131629.","DOI":"10.1016\/S0735-1097(02)01814-4"},{"key":"key\n\t\t\t\t20171012095750_EHI178C32","doi-asserted-by":"crossref","unstructured":"Houghton AR, Sparrow NJ, Cowley AJ. Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography? Int J Cardiol1997;62:31\u201336.","DOI":"10.1016\/S0167-5273(97)00181-2"},{"key":"key\n\t\t\t\t20171012095750_EHI178C33","doi-asserted-by":"crossref","unstructured":"Nielsen OW, Hilden J, Hansen JF. Strong prognostic value of combining N-terminal atrial natriuretic peptide and ECG to predict death in heart patients from general practice. Heart2001;86:218\u2013219.","DOI":"10.1136\/heart.86.2.218"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/26\/11\/1086\/9623143\/ehi178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T09:32:43Z","timestamp":1586165563000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/eurheartj\/article\/26\/11\/1086\/560940\/Using-BNP-to-develop-a-risk-score-for-heart"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,15]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,3,15]]},"published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehi178","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,6]]},"published":{"date-parts":[[2005,3,15]]}}}